美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=DAPTOMYCIN"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
DAPTOMYCIN 203797 001 NDA DAPTOMYCIN POWDER;INTRAVENOUS 350MG/VIAL No 2013/03/15 (TA) HOSPIRA INC None (Tentative Approval)
DAPTOMYCIN 202857 001 ANDA DAPTOMYCIN POWDER;INTRAVENOUS 500MG/VIAL No No 2014/09/12 2014/09/12 HOSPIRA INC Prescription
DAPTOMYCIN 091039 001 ANDA DAPTOMYCIN POWDER;INTRAVENOUS 500MG/VIAL No No 2016/03/25 2016/03/25 TEVA PHARMS USA Prescription
DAPTOMYCIN 206005 001 ANDA DAPTOMYCIN POWDER;INTRAVENOUS 500MG/VIAL No No 2016/06/15 2016/06/15 XELLIA PHARMS APS Prescription
DAPTOMYCIN 208385 001 NDA DAPTOMYCIN POWDER;IV (INFUSION) 350MG/VIAL Yes Yes 2017/09/12 2017/09/12 SAGENT PHARMS INC Prescription
DAPTOMYCIN 209949 001 NDA DAPTOMYCIN POWDER;IV (INFUSION) 350MG/VIAL Yes Yes 2017/10/20 2017/10/20 XELLIA PHARMS APS Prescription
DAPTOMYCIN 206077 001 ANDA DAPTOMYCIN POWDER;INTRAVENOUS 500MG/VIAL No No 2018/04/11 2018/04/11 FRESENIUS KABI USA Prescription
DAPTOMYCIN 205037 001 ANDA DAPTOMYCIN POWDER;INTRAVENOUS 500MG/VIAL No No 2018/06/05 2018/06/05 MYLAN LABS LTD Prescription
DAPTOMYCIN 208375 001 ANDA DAPTOMYCIN POWDER;INTRAVENOUS 500MG/VIAL No No 2019/05/01 2019/05/01 DR REDDYS Prescription
DAPTOMYCIN 211961 001 ANDA DAPTOMYCIN POWDER;INTRAVENOUS 500MG/VIAL No No 2019/06/24 2019/06/24 ACCORD HLTHCARE Prescription
DAPTOMYCIN 212513 001 ANDA DAPTOMYCIN POWDER;INTRAVENOUS 500MG/VIAL No No 2019/06/26 2019/06/26 BE PHARMS Prescription
DAPTOMYCIN 212667 001 ANDA DAPTOMYCIN POWDER;IV (INFUSION) 350MG/VIAL No No 2019/07/12 2019/07/12 ACCORD HLTHCARE Prescription
DAPTOMYCIN 212022 001 ANDA DAPTOMYCIN POWDER;INTRAVENOUS 500MG/VIAL No No 2019/08/22 2019/08/22 JIANGSU HENGRUI MED Prescription
药品名称,活性成分,申请号搜索 高级检索
©2006-2019 DrugFuture->U.S. FDA Drugs Database